<p>许多 <strong>Prestige Consumer Healthcare Inc.</strong> (NYSE:PBH) 的内部人士在过去一年里抛售了他们的股票，这可能引起公司股东的关注。了解内部人士是否在买入通常在评估内部交易时更为有用，因为内部人士的卖出可能有多种解释。然而，如果许多内部人士都在卖出，股东应该进一步调查。</p>
<p>尽管我们认为股东不应仅仅跟随内部交易，但逻辑上你应该关注内部人士是否在买入或卖出股票。</p>
<p>特朗普承诺要 “释放” 美国的石油和天然气，这 15 只美国股票的发展有望受益。</p>
<h2>Prestige Consumer Healthcare 最近一年的内部交易</h2>
<p>在过去的十二个月中，内部人士最大的单笔出售是质量与监管事务高级副总裁 Mary Fritz 以每股 81.99 美元的价格出售了价值 81 万美元的股票。我们通常不喜欢看到内部人士的卖出，但卖出价格越低，我们越感到担忧。值得安慰的是，这笔交易的价格远高于当前的股价 65.05 美元。因此，这可能对当前水平的内部信心没有太多启示。</p>
<p>在过去一年中，Prestige Consumer Healthcare 的内部人士没有购买任何公司股票。你可以在下面的图表中看到过去一年内部交易（按公司和个人划分）的情况。点击下面的图表，你可以查看每笔内部交易的具体细节！</p>
<p>查看我们对 Prestige Consumer Healthcare 的最新分析</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/10969688-insider-trading-volume-1-dark-2/1757246984388?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/10969688-insider-trading-volume-1-dark-2/1757246984388"/></p>
<p>NYSE:PBH 内部交易量 2025 年 9 月 7 日</p>
<p>如果你和我一样，那么你一定不想错过这份 <strong>免费的</strong> 小型股名单，这些股票不仅被内部人士购买，而且估值也很有吸引力。</p>
<h2>内部持股</h2>
<p>我喜欢查看内部人士在公司中拥有多少股份，以帮助我判断他们与内部人士的利益一致性。通常，内部持股越高，内部人士越有可能受到激励以长期发展公司。内部人士拥有 1.1% 的 Prestige Consumer Healthcare 股票，价值约 3700 万美元。这个内部持股水平不错，但略低于特别突出。它确实表明了一定程度的利益一致性。</p>
<h2>那么 Prestige Consumer Healthcare 的内部交易表明了什么？</h2>
<p>最近没有 Prestige Consumer Healthcare 的内部交易，这一点确实不会让我们感到困扰。我们对 Prestige Consumer Healthcare 内部人士的交易并没有太多鼓励。适度的内部持股水平至少让人感到一些安慰。虽然了解内部人士的持股和交易情况是好的，但在做出任何投资决策之前，我们也确保考虑股票面临的风险。在投资风险方面，我们已经识别出 <strong>1 个警示信号</strong>，了解这一点应该是你投资过程的一部分。</p>
<p>如果你更愿意查看另一家公司——一家可能财务状况更优越的公司——那么不要错过这份 <strong>免费的</strong> 有趣公司名单，这些公司具有高股本回报率和低债务。</p>
<p><em>在本文中，内部人士是指向相关监管机构报告其交易的个人。我们目前仅考虑公开市场交易和直接利益的私人处置，但不包括衍生交易或间接利益。</em></p>

普雷斯蒂奇

<p>Prestige Consumer Healthcare Inc.（纽约证券交易所代码：PBH）的内部人士在过去一年中出售了大量股票，这引发了股东的担忧。最大的一笔出售是由高级副总裁 Mary Fritz 进行的，她以每股 81.99 美元的价格出售了价值 81 万美元的股票，远高于当前的 65.05 美元价格。最近没有内部人士购买股票，内部持股比例为 1.1%。虽然近期缺乏交易并不令人担忧，但这表明股东在投资前需要考虑潜在风险</p>

<p>Many <strong>Prestige Consumer Healthcare Inc.</strong> (NYSE:PBH) insiders ditched their stock over the past year, which may be of interest to the company's shareholders. Knowing whether insiders are buying is usually more helpful when evaluating insider transactions, as insider selling can have various explanations. However, if numerous insiders are selling, shareholders should investigate more.</p>
<div class="lb-trans"><p>许多 <strong>Prestige Consumer Healthcare Inc.</strong> (NYSE:PBH) 的内部人士在过去一年里抛售了他们的股票，这可能引起公司股东的关注。了解内部人士是否在买入通常在评估内部交易时更为有用，因为内部人士的卖出可能有多种解释。然而，如果许多内部人士都在卖出，股东应该进一步调查。</p>
</div><p>Although we don't think shareholders should simply follow insider transactions, logic dictates you should pay some attention to whether insiders are buying or selling shares.</p>
<div class="lb-trans"><p>尽管我们认为股东不应仅仅跟随内部交易，但逻辑上你应该关注内部人士是否在买入或卖出股票。</p>
</div><p>Trump has pledged to &#34;unleash&#34; American oil and gas and these 15 US stocks have developments that are poised to benefit.</p>
<div class="lb-trans"><p>特朗普承诺要 “释放” 美国的石油和天然气，这 15 只美国股票的发展有望受益。</p>
</div><h2>Prestige Consumer Healthcare Insider Transactions Over The Last Year</h2>
<div class="lb-trans"><h2>Prestige Consumer Healthcare 最近一年的内部交易</h2>
</div><p>In the last twelve months, the biggest single sale by an insider was when the Senior Vice President of Quality &amp; Regulatory Affairs, Mary Fritz, sold US$810k worth of shares at a price of US$81.99 per share. We generally don't like to see insider selling, but the lower the sale price, the more it concerns us. It's of some comfort that this sale was conducted at a price well above the current share price, which is US$65.05. So it may not shed much light on insider confidence at current levels.</p>
<div class="lb-trans"><p>在过去的十二个月中，内部人士最大的单笔出售是质量与监管事务高级副总裁 Mary Fritz 以每股 81.99 美元的价格出售了价值 81 万美元的股票。我们通常不喜欢看到内部人士的卖出，但卖出价格越低，我们越感到担忧。值得安慰的是，这笔交易的价格远高于当前的股价 65.05 美元。因此，这可能对当前水平的内部信心没有太多启示。</p>
</div><p>In the last year Prestige Consumer Healthcare insiders didn't buy any company stock. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. By clicking on the graph below, you can see the precise details of each insider transaction!</p>
<div class="lb-trans"><p>在过去一年中，Prestige Consumer Healthcare 的内部人士没有购买任何公司股票。你可以在下面的图表中看到过去一年内部交易（按公司和个人划分）的情况。点击下面的图表，你可以查看每笔内部交易的具体细节！</p>
</div><p>See our latest analysis for Prestige Consumer Healthcare</p>
<div class="lb-trans"><p>查看我们对 Prestige Consumer Healthcare 的最新分析</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/10969688-insider-trading-volume-1-dark-2/1757246984388" alt="" original-src="https://images.simplywall.st/asset/chart/10969688-insider-trading-volume-1-dark-2/1757246984388"/></p>
<p>NYSE:PBH Insider Trading Volume September 7th 2025</p>
<div class="lb-trans"><p>NYSE:PBH 内部交易量 2025 年 9 月 7 日</p>
</div><p>If you are like me, then you will <strong>not</strong> want to miss this <strong>free</strong> list of small cap stocks that are not only being bought by insiders but also have attractive valuations.</p>
<div class="lb-trans"><p>如果你和我一样，那么你一定不想错过这份 <strong>免费的</strong> 小型股名单，这些股票不仅被内部人士购买，而且估值也很有吸引力。</p>
</div><h2>Insider Ownership</h2>
<div class="lb-trans"><h2>内部持股</h2>
</div><p>I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. Insiders own 1.1% of Prestige Consumer Healthcare shares, worth about US$37m. This level of insider ownership is good but just short of being particularly stand-out. It certainly does suggest a reasonable degree of alignment.</p>
<div class="lb-trans"><p>我喜欢查看内部人士在公司中拥有多少股份，以帮助我判断他们与内部人士的利益一致性。通常，内部持股越高，内部人士越有可能受到激励以长期发展公司。内部人士拥有 1.1% 的 Prestige Consumer Healthcare 股票，价值约 3700 万美元。这个内部持股水平不错，但略低于特别突出。它确实表明了一定程度的利益一致性。</p>
</div><h2>So What Do The Prestige Consumer Healthcare Insider Transactions Indicate?</h2>
<div class="lb-trans"><h2>那么 Prestige Consumer Healthcare 的内部交易表明了什么？</h2>
</div><p>The fact that there have been no Prestige Consumer Healthcare insider transactions recently certainly doesn't bother us. We don't take much encouragement from the transactions by Prestige Consumer Healthcare insiders. The modest level of insider ownership is, at least, some comfort. While it's good to be aware of what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. In terms of investment risks, <strong>we've identified 1 warning sign</strong> with Prestige Consumer Healthcare and understanding this should be part of your investment process.</p>
<div class="lb-trans"><p>最近没有 Prestige Consumer Healthcare 的内部交易，这一点确实不会让我们感到困扰。我们对 Prestige Consumer Healthcare 内部人士的交易并没有太多鼓励。适度的内部持股水平至少让人感到一些安慰。虽然了解内部人士的持股和交易情况是好的，但在做出任何投资决策之前，我们也确保考虑股票面临的风险。在投资风险方面，我们已经识别出 <strong>1 个警示信号</strong>，了解这一点应该是你投资过程的一部分。</p>
</div><p>If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this <strong>free</strong> list of interesting companies, that have HIGH return on equity and low debt.</p>
<div class="lb-trans"><p>如果你更愿意查看另一家公司——一家可能财务状况更优越的公司——那么不要错过这份 <strong>免费的</strong> 有趣公司名单，这些公司具有高股本回报率和低债务。</p>
</div><p><em>For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.</em></p>
<div class="lb-trans"><p><em>在本文中，内部人士是指向相关监管机构报告其交易的个人。我们目前仅考虑公开市场交易和直接利益的私人处置，但不包括衍生交易或间接利益。</em></p>
</div>

普雷斯蒂奇消费者医疗保健公司的内部人士正在出售股票，这可能是一个看跌信号